Used in pharmaceutical research as a key intermediate in the development of kinase inhibitors, particularly for targeted cancer therapies. It exhibits potential in modulating specific signaling pathways involved in tumor growth and proliferation. Due to its fluorinated aromatic structure and piperidine-carbonyl moiety, it enhances binding selectivity and metabolic stability in drug candidates. Currently investigated for use in treatments of solid tumors and hematologic malignancies. Also employed in structure-activity relationship (SAR) studies to optimize potency and pharmacokinetic properties of new drug formulations.